These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23737042)

  • 1. The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro.
    Ghahghaei A; Bathaie SZ; Kheirkhah H; Bahraminejad E
    Cell Mol Biol Lett; 2013 Sep; 18(3):328-39. PubMed ID: 23737042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
    Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
    Singh PK; Maji SK
    Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
    De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
    J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species.
    Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D
    J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E22G Pathogenic Mutation of β-Amyloid (Aβ) Enhances Misfolding of Aβ40 by Unexpected Prion-like Cross Talk between Aβ42 and Aβ40.
    Yoo BK; Xiao Y; McElheny D; Ishii Y
    J Am Chem Soc; 2018 Feb; 140(8):2781-2784. PubMed ID: 29425039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro.
    Ahmad A; Muzaffar M; Ingram VM
    Biochim Biophys Acta; 2009 Oct; 1794(10):1537-48. PubMed ID: 19595795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation.
    Dammers C; Reiss K; Gremer L; Lecher J; Ziehm T; Stoldt M; Schwarten M; Willbold D
    Biophys J; 2017 Apr; 112(8):1621-1633. PubMed ID: 28445753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.
    Jan A; Gokce O; Luthi-Carter R; Lashuel HA
    J Biol Chem; 2008 Oct; 283(42):28176-89. PubMed ID: 18694930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
    Hojati S; Ghahghaei A; Lagzian M
    J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ(39-42) modulates Aβ oligomerization but not fibril formation.
    Gessel MM; Wu C; Li H; Bitan G; Shea JE; Bowers MT
    Biochemistry; 2012 Jan; 51(1):108-17. PubMed ID: 22129303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.
    Sato T; Kienlen-Campard P; Ahmed M; Liu W; Li H; Elliott JI; Aimoto S; Constantinescu SN; Octave JN; Smith SO
    Biochemistry; 2006 May; 45(17):5503-16. PubMed ID: 16634632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
    Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-micellar ganglioside GM1 induces an instantaneous conformational change in Aβ
    Kumar M; Ivanova MI; Ramamoorthy A
    Biophys Chem; 2023 Oct; 301():107091. PubMed ID: 37549471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
    Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
    Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
    Loureiro JA; Rocha S; Pereira Mdo C
    J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.